Overall rank by patents
#21,033
of 50,000 tracked assignees
USPTO PatentsView assignee record - 13 granted patents across 4 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61G (TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS ; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES).
The verdict
According to USPTO PatentsView, D.t. ranks #21,033 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 4 technology areas.
USPTO PatentsView assignee plate
Corpus R21033 · US Corporation #21,033 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Currax Pharmaceuticals Llc (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
D t Davis Enterprises · this assignee
47 score
3D Lighting Innovati… · lowest
7 score
What this shows D.t.'s Innovation Score is 47.3/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
D.t. Davis Enterprises, Ltd. is a focused PatentsView assignee: 4 CPC subclasses with 92.3% of grants classified under A61G (TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS ; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES). Peak complete grant year is 2022 (6 grants) versus a trough of 1 in 2024. By volume, D.t. sits between Currax Pharmaceuticals Llc and DBG Group Investments, Llc.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Currax Pharmaceuticals LLC
13 patents
Cyboenergy, Inc.
13 patents
Cytrellis Biosystems, Inc.
13 patents
D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.
13 patents
DAIICHI SANKYO EUROPE GMBH
13 patents
DAJ GLOBAL PARTNERS LLC
13 patents
DASHAMERICA, INC.
13 patents
DBG GROUP INVESTMENTS, LLC
13 patents
D.T. Davis Enterprises, Ltd.
13 patents
What this shows D.t. holds 13 patents at rank #20,984, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #20,984 in granted patent volume.
Other assignees with the most granted patents in Dt's primary technology class.
D.t.'s Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
47 Top 19% higher than 81% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 2 | 15.4% |
| 2022 | 6 | 46.2% |
| 2023 | 2 | 15.4% |
| 2024 | 1 | 7.7% |
| 2025partial year | 2 | 15.4% |
Top 4 of 4 technology areas
Overall rank by patents
#21,033
of 50,000 tracked assignees
47.3 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.